Health and Fitness Health and Fitness
Wed, October 12, 2011
[ Wed, Oct 12th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. n Pharmaceuticals, Inc. and Trustmark Corporation
[ Wed, Oct 12th 2011 ] - Market Wire
Implant Sciences Receives Orders for the QS-B220 .. ench-Top Explosives and Narcotics Trace Detectors
[ Wed, Oct 12th 2011 ] - Market Wire
OPKO Completes Sale of Ophthalmic Instrumentation Business
[ Wed, Oct 12th 2011 ] - Market Wire
Data Presented at the 5th Joint Triennial Congres .. nstrates Biogen Ideca?s Novel Science and Commitm
[ Wed, Oct 12th 2011 ] - Market Wire
Study Supports Use of Cambridge Hearta?s MTWA Test as Predictor of Sudden Cardiac Death
[ Wed, Oct 12th 2011 ] - Market Wire
SciClone Pharmaceuticals Announces Preliminary Settlement of Stockholder Derivative Litigation
[ Wed, Oct 12th 2011 ] - Market Wire
Galectin Therapeutics Elects Dr. Marc Rubin to its Board of Directors
[ Wed, Oct 12th 2011 ] - Market Wire
Illumina Announces Novel Human Exome Content Available on Multiple BeadChip Formats
Tue, October 11, 2011
[ Tue, Oct 11th 2011 ] - Market Wire
Molina Healthcare of Missouri Receives aCommendablea? NCQA Status
[ Tue, Oct 11th 2011 ] - Market Wire
St. Jude Medical verbessert sein Patientenfernber .. gssystem durch mobile Benachrichtigungsfunktionen
[ Tue, Oct 11th 2011 ] - Market Wire
Healthnostics Launching MicroFill-2160 1st Quarter 2012
[ Tue, Oct 11th 2011 ] - Market Wire
Glamsmile Opens Rome Studio, With the Wenzhou Studio Opening to Follow Shortly Thereafter
[ Tue, Oct 11th 2011 ] - Market Wire
International Stem Cell's Research Scientists Suc .. t Series of Preclinical Animal Trials of Neuronal
[ Tue, Oct 11th 2011 ] - Market Wire
BioSante Pharmaceuticals Reports Positive LibiGel® Safety Data Review in Phase III Program
[ Tue, Oct 11th 2011 ] - Market Wire
Breakthrough in Multiple Sclerosis Achieved by FO .. IGHT MRI Announced at UC San Diego Medical Center
[ Tue, Oct 11th 2011 ] - Market Wire
Aetna??Michael Elliott???????
[ Tue, Oct 11th 2011 ] - Market Wire
Illumina Introduces Revolutionary Workflow Enhancements for MiSeqa"
Mon, October 10, 2011
[ Mon, Oct 10th 2011 ] - Market Wire
Health Net Receives Full URAC Accreditation for Disease Management
[ Mon, Oct 10th 2011 ] - Market Wire
Innovative Pipelines From Avanir and Cyclacel Pharmaceuticals Gain Momentum
[ Mon, Oct 10th 2011 ] - Market Wire
Equity Research on Humana Inc. and WellPoint Inc. - Obamacare Helping Several Health Insurers
[ Mon, Oct 10th 2011 ] - Market Wire
St. Jude Medical Advances Its Remote Patient Monitoring System with Mobile Notifications
[ Mon, Oct 10th 2011 ] - Market Wire
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn®
[ Mon, Oct 10th 2011 ] - Market Wire
Natus Medical Announces Preliminary 2011 Third Quarter Revenue Results
[ Mon, Oct 10th 2011 ] - Market Wire
Medtronic Announces Results from TTOP-AF Trial De .. of Its Phased RF Ablation System in Treating Per
[ Mon, Oct 10th 2011 ] - Market Wire
PAREXEL and National University of Singapore Esta .. Meet Increasing Demand in Asia for Clinical Rese
[ Mon, Oct 10th 2011 ] - Market Wire
Inovio Pharmaceuticals and VGX International to A .. C and Hepatitis B Synthetic Vaccines into Clinica
Sun, October 9, 2011
[ Sun, Oct 09th 2011 ] - Market Wire
Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
[ Sun, Oct 09th 2011 ] - Market Wire
Mylan Comments on Death of Company Co-Founder and Former Chairman and CEO Milan "Mike" Puskar
Sat, October 8, 2011
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. Daily Therapy for Patients with Type 2 Diabetes W
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. 9;; a Once-Daily Therapy for Patients with
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. ;;; a Once-Daily Therapy for Patients w
[ Sat, Oct 08th 2011 ] - Market Wire
FDA Approves Mercka?s JUVISYNCa" (sitagliptin and .. e-Daily Therapy for Patients with Type 2 Diabetes
[ Sat, Oct 08th 2011 ] - Market Wire
KCI Announces Proposed Offering of Senior Notes
[ Sat, Oct 08th 2011 ] - Market Wire
Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
[ Sat, Oct 08th 2011 ] - Market Wire
West Increases Quarterly Dividend to $0.18
[ Sat, Oct 08th 2011 ] - Market Wire
Amerigroup Enhances Maternal Outreach Efforts
[ Sat, Oct 08th 2011 ] - Market Wire
IBM Launches University Competition to Combat Growth of Non-Communicable Diseases
Fri, October 7, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
Celgene publica nueva informacin adicional sobre la conclusin del Artculo 20 para REVLIMID®
[ Fri, Oct 07th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Continues Inve .. ation of Pharmaceutical Product Development, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
MEDNAX 2011 Third Quarter Conference Call/Webcast Scheduled for Tuesday, November 1, 2011
[ Fri, Oct 07th 2011 ] - Market Wire
Vertex Announces the Date of its Third Quarter 2011 Financial Results Conference Call and Webcast
[ Fri, Oct 07th 2011 ] - Market Wire
Cardiovascular Systems Announces Preliminary First-Quarter Financial Results
[ Fri, Oct 07th 2011 ] - Market Wire
Analyst View, Impact of Global Events - Research .. n MELA Sciences, Inc. and SIGA Technologies, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Expert's Economic Outlook, Global - Equity Resear .. harmaceutical Companies, Inc. and Targacept, Inc.
[ Fri, Oct 07th 2011 ] - Market Wire
Adherex Reports Meeting With FDA's Pediatric Subc .. gs Advisory Committee on the Development of Sodiu
[ Fri, Oct 07th 2011 ] - Market Wire
Senetek Announces Work Plans at Iron Creek Project
Thu, October 6, 2011
[ Thu, Oct 06th 2011 ] - Market Wire
Hansen Medical Announces Settlement of SEC Investigation
[ Thu, Oct 06th 2011 ] - Market Wire
Patient Home Monitoring Announces Unaudited Reven .. for September 2011, and Growth Figures for Q4 20
[ Thu, Oct 06th 2011 ] - Market Wire
Equity Research on Gilead Sciences Inc. and Human .. . - Regulatory Approval Key for Biotech Companies
[ Thu, Oct 06th 2011 ] - Market Wire
Peregrine Completes Patient Enrollment in Second- .. er Trial;; Data to Be Unblinded in First H
[ Thu, Oct 06th 2011 ] - Market Wire
Trimel Provides Update on Female Sexual Dysfunction "Anorgasmia" Clinical Program
[ Thu, Oct 06th 2011 ] - Market Wire
Threshold Pharmaceuticals to Present at the BioCentury NewsMakers Conference
[ Thu, Oct 06th 2011 ] - Market Wire
Alexza and Grupo Ferrer Establish Partnership for .. uvea" (Staccato® Loxapine) in Europe and Latin A
[ Thu, Oct 06th 2011 ] - Market Wire
Greystone Logistics Announces Record Sales in 4th Quarter
[ Thu, Oct 06th 2011 ] - Market Wire
The Ensign Group Acquires La Jolla Skilled Nursing Facility
Wed, October 5, 2011
[ Wed, Oct 05th 2011 ] - Market Wire
Basilea receives request for extraordinary shareh .. lect additional members to the board of directors
[ Wed, Oct 05th 2011 ] - Market Wire
Waters Empowers Advantar Laboratories for Sustained Growth
[ Wed, Oct 05th 2011 ] - Market Wire
Investigational Oral Multiple Sclerosis Therapy T .. ignificantly Reduced Relapse Rate, Disability Pro
[ Wed, Oct 05th 2011 ] - Market Wire
MURRAY FRANK LLP Announces Investigation of Pharmaceutical Product Development, Inc.
[ Wed, Oct 05th 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Investigation of DaVita, Inc.
[ Wed, Oct 05th 2011 ] - Market Wire
Voclosporin study published in the American Journal of Transplantation
[ Wed, Oct 05th 2011 ] - Market Wire
OncoSec Releases Devices for Use in Clinical Trials
[ Wed, Oct 05th 2011 ] - Market Wire
Inovio Pharmaceuticals' Synthetic Vaccine for Can .. ost Promising Research at Global Vaccine Congress
Tue, October 4, 2011
[ Tue, Oct 04th 2011 ] - Market Wire
Law Offices of Howard G. Smith LLP Announces Inve .. ation of Pharmaceutical Product Development, Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Bronstein, Gewirtz & Grossman, LLC Investigates DaVita, Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
POZEN Provides Patent Litigation and Financial Guidance Update
[ Tue, Oct 04th 2011 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Pharmaceutical Product Development Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Ryan & Maniskas, LLP Announces Investigation of Pharmaceutical Product Development Inc.
[ Tue, Oct 04th 2011 ] - Market Wire
Neurocrine Biosciences Receives Second Milestone .. $20 Million Under Abbott Collaboration Agreement
[ Tue, Oct 04th 2011 ] - Market Wire
Investigation of Pharmaceutical Product Developme .. oldfarb Branham Law Firm LLP for Potential Shareh
[ Tue, Oct 04th 2011 ] - Market Wire
BD Announces Live Webcast of Fourth Fiscal Quarter Earnings Conference Call
[ Tue, Oct 04th 2011 ] - Market Wire
Initial Data from Bio-Path Holdingsa? Phase I Cli .. entation at American Society of Hematology Annual
Mon, October 3, 2011
[ Mon, Oct 03rd 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Inve .. tion of Pharmaceuticals Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2011 Results
[ Mon, Oct 03rd 2011 ] - Market Wire
The Law Firm of Levi & Korsinsky, LLP Announces I .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Tripp Levy PLLC Announces Investigation of Pharmaceutical Product Development
[ Mon, Oct 03rd 2011 ] - Market Wire
The Briscoe Law Firm and Powers Taylor, LLP Annou .. ation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Rigrodsky & Long, P.A. Announces Investigation of Pharmaceutical Product Development, Inc.
[ Mon, Oct 03rd 2011 ] - Market Wire
Medwell Capital to Adopt IFRS
[ Mon, Oct 03rd 2011 ] - Market Wire
IMRIS Announces Retirement of Chief Operating Officer
[ Mon, Oct 03rd 2011 ] - Market Wire
Allegiance Completes Private Placement Of 229,166 Common At $0.48 Per Share
Sun, October 2, 2011
[ Sun, Oct 02nd 2011 ] - Market Wire
HeartWare Reports Additional Clinical Data From B .. nued Access Patients at the 25th European Associa
Sat, October 1, 2011
[ Sat, Oct 01st 2011 ] - Market Wire
HealthSpring Unveils 2012 Medicare Advantage Plans
Fri, September 30, 2011
[ Fri, Sep 30th 2011 ] - Market Wire
AxoGen, Inc. Announces Completion of Merger, Name Change and Executive Team Changes
[ Fri, Sep 30th 2011 ] - Market Wire
Health Management Associates, Inc. Completes the .. alth Partners from Catholic Health Partners, Inc.
[ Fri, Sep 30th 2011 ] - Market Wire
Merck Announces New Data Analyses for VICTRELISa" .. ed at The American Association for the Study of L
[ Fri, Sep 30th 2011 ] - Market Wire
Vertex to Present New Data from Hepatitis C Development Program at AASLD Annual Meeting
[ Fri, Sep 30th 2011 ] - Market Wire
Reminding Seniors to Be Mindful of Medications
[ Fri, Sep 30th 2011 ] - Market Wire
Merck to Hold Third-Quarter 2011 Sales and Earnings Conference Call on October 28
[ Fri, Sep 30th 2011 ] - Market Wire
A Randomized Phase 2 Study of Selumetinib in Patients with KRAS-Mutant Non-Small Cell Lung Cancer
[ Fri, Sep 30th 2011 ] - Market Wire
ShangPharma to Attend Upcoming Investor Conferences in October
[ Fri, Sep 30th 2011 ] - Market Wire
Concord Medical Services Announces Share Repurchase Program
Thu, September 29, 2011
[ Thu, Sep 29th 2011 ] - Market Wire
Boston Scientific Begins Enrollment in NECTAR-HF Clinical Trial
[ Thu, Sep 29th 2011 ] - Market Wire
Biogen Idec bevordert Tony Kingsley tot hoofd van Global Commercial Operations
[ Thu, Sep 29th 2011 ] - Market Wire
Galectin Therapeutics Posts New Corporate Presentation Video to its Website
[ Thu, Sep 29th 2011 ] - Market Wire
SANUWAVE Appoints Private Equity Veteran Barbara M. Henagan to Its Board of Directors
[ Thu, Sep 29th 2011 ] - Market Wire
The National Association Of Boards Of Pharmacy An .. Patients About The Flood Of Counterfeit Medicines
[ Thu, Sep 29th 2011 ] - Market Wire
Federal Fire Department in Pearl Harbor Uses ZOLL .. ave 37-Year-Old Seaman from Sudden Cardiac Arrest
[ Thu, Sep 29th 2011 ] - Market Wire
NanoViricides Inc Files For Extension of Form 10-K Annual Report Submission Date
[ Thu, Sep 29th 2011 ] - Market Wire
Illumina Introduces Low-Cost Bovine BeadChip for Genotyping of Dairy Cattle
[ Thu, Sep 29th 2011 ] - Market Wire
Chronic Conditions Cost UK Economy More Than 20 Billion Pounds a Year
Wed, September 28, 2011
[ Wed, Sep 28th 2011 ] - Market Wire
Five Days Remain before Deadline in Class-action Lawsuit against Dendreon, Says Hagens Berman
[ Wed, Sep 28th 2011 ] - Market Wire
HeartWare Announces Presentation of Clinical Data .. tion for Cardio-Thoracic Surgery (EACTS) Annual M
[ Wed, Sep 28th 2011 ] - Market Wire
BioDelivery Sciences Announces Results from Phase .. cacy Study for BEMA Buprenorphine in Chronic Pain
[ Wed, Sep 28th 2011 ] - Market Wire
Experts to Provide Successful Strategies for Glob .. ent and Commercialization at PAREXEL Tokyo Semina
[ Wed, Sep 28th 2011 ] - Market Wire
Boston Scientific Announces Favorable Appellate C .. ming Non-Infringement of Johnson & Johnson Patent
[ Wed, Sep 28th 2011 ] - Market Wire
Merck Sells Its Interest in Johnson & Johnson-Merck Consumer Pharmaceuticals
[ Wed, Sep 28th 2011 ] - Market Wire
IntegraMed Promotes Tim Sheehan to SVP and CFO
[ Wed, Sep 28th 2011 ] - Market Wire
ImmunoCellular Therapeuticsa? ICT-107 Recognized .. hovera?s Top 10 Most Licensable Oncology Products
[ Wed, Sep 28th 2011 ] - Market Wire
Amyris e Michelin Anunciam Colaborao para Desenvolver e Comercializar Isopreno de Fontes Renovveis
Tue, September 27, 2011
[ Tue, Sep 27th 2011 ] - Market Wire
Gallup und Healthways verffentlichen erste Ergebn .. s Well-Being (Wohlbefindens)-Index fr Deutschland
[ Tue, Sep 27th 2011 ] - Market Wire
HCA Announces Proposed Public Offering of $500 Million Senior Notes
[ Tue, Sep 27th 2011 ] - Market Wire
Catasys Launches Its Integrated Substance Dependence Program in Massachusetts
[ Tue, Sep 27th 2011 ] - Market Wire
Merck Names Cuong Viet Do as Chief Strategy Officer
[ Tue, Sep 27th 2011 ] - Market Wire
POZEN Announces October 4, 2011 Mid-Quarter Update and Financial Guidance Webcast
[ Tue, Sep 27th 2011 ] - Market Wire
BioLineRx to Present Data from the Successfully C .. L-1020 at European Conference on Schizophrenia Re
[ Tue, Sep 27th 2011 ] - Market Wire
Molina Healthcare Names Michael Steele as Senior Vice President of Dual Eligible Strategies
[ Tue, Sep 27th 2011 ] - Market Wire
Alexion recibe opinin positiva del CHMP para Soli .. s con sndrome ur©mico hemoltico atpico (aHUS) en
[ Tue, Sep 27th 2011 ] - Market Wire
Evidence of AT13387 Activity in Gastrointestinal Stromal Tumor Models Presented at ECCO
Mon, September 26, 2011
[ Mon, Sep 26th 2011 ] - Market Wire
Guidance For Cannabis Science Brand Products To B .. lorado Based On Accumulating Anecdotal Reports Of
[ Mon, Sep 26th 2011 ] - Market Wire
Health Net Sponsors 2011 Congressional Medal of Honor Convention and Star-Studded Tribute Concert
[ Mon, Sep 26th 2011 ] - Market Wire
Zynex Receives FDA 510(k) Clearance for the NexWave Medical Device
[ Mon, Sep 26th 2011 ] - Market Wire
Alnylam Initiates Phase I Clinical Study of ALN-P .. ting PCSK9 for the Treatment of Severe Hyperchole
[ Mon, Sep 26th 2011 ] - Market Wire
Synta Announces Presentation of Results of Ganete .. udy in Combination with Docetaxel in Solid Tumors
[ Mon, Sep 26th 2011 ] - Market Wire
iCo Therapeutics and JDRF Partner to Investigate iCo-007 in Diabetic Macular Edema
[ Mon, Sep 26th 2011 ] - Market Wire
ARIAD Announces Long-Term Follow Up of Patients w .. stant CML Treated with Ponatinib in Phase 1 Trial
[ Mon, Sep 26th 2011 ] - Market Wire
Millennium y Seattle Genetics presentan datos cln .. uximab Vedotin) en pacientes peditricos en reunin
[ Mon, Sep 26th 2011 ] - Market Wire
National Hospice and Palliative Care Expert Joins Amedisys
Sat, September 24, 2011
[ Sat, Sep 24th 2011 ] - Market Wire
FDA lsst Soliris® (Eculizumab) zur Behandlung al .. atypischem hmolytisch-urmischem Syndrom (aHUS) zu
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium en Seattle Genetics presenteren klinis .. brentuximab vedotin) bij pediatrische patinten op
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium e Seattle Genetics presentano dati cli .. ab vedotin) nei pazienti pediatrici all'&
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent, la?oc .. de la?EMCC, des donn©es cliniques concernant la?
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium und Seattle Genetics legen auf der EMC .. n zu ADCETRISa" (Brentuximab Vedotin) bei pdiatri
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent la?occ .. e la?EMCC des donn©es cliniques concernant la?ut
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium et Seattle Genetics pr©sentent, .. occasion de la r©union annuelle de la?EMCC,&#
[ Sat, Sep 24th 2011 ] - Market Wire
Millennium and Seattle Genetics Present Clinical .. mab Vedotin) in Pediatric Patients at EMCC Annual
Fri, September 23, 2011
[ Fri, Sep 23rd 2011 ] - Market Wire
Robbins Geller Rudman & Dowd LLP Files Class Action Suit against Allos Therapeutics, Inc.
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene: reglementaire update inzake REVLIMID
[ Fri, Sep 23rd 2011 ] - Market Wire
Glancy Binkow & Goldberg LLP Announces Investigation of American Medical Alert Corp.
[ Fri, Sep 23rd 2011 ] - Market Wire
European CHMP Adopts Positive Opinion for Evipler .. Tablet Regimen for the Treatment of HIV Infection
[ Fri, Sep 23rd 2011 ] - Market Wire
MISE JOUR RGLEMENTAIRE DE CELGENE AU SUJET DE REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene prsentiert aktuelle Informationen zur Marktzulassung von REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
AGGIORNAMENTO REGOLATORIO DI CELGENE CIRCA REVLIMID®
[ Fri, Sep 23rd 2011 ] - Market Wire
Celgene Regulatory Update on REVLIMID®
Thu, September 22, 2011
[ Thu, Sep 22nd 2011 ] - Market Wire
Enzon Announces Reduction in Force to Align Operations with Research and Development Activities
[ Thu, Sep 22nd 2011 ] - Market Wire
U.S. Physical Therapy to Present at the The Sixth Annual JMP Securities Healthcare Conference
[ Thu, Sep 22nd 2011 ] - Market Wire
Brain Resource Opens U.S. Headquarters in San Francisco
[ Thu, Sep 22nd 2011 ] - Market Wire
PFCD Hill Briefing Demonstrates How Health Indices Promote Prevention and Improve Overall Health
[ Thu, Sep 22nd 2011 ] - Market Wire
Law Office of Brodsky & Smith, LLC Announces Class Action Lawsuit Against Dendreon Corporation
[ Thu, Sep 22nd 2011 ] - Market Wire
dermaPACE Pivotal Phase III Clinical Trial Data i .. r Healing to Be Presented at Plastic Surgery 2011
[ Thu, Sep 22nd 2011 ] - Market Wire
Columbia Laboratories Extends Stockholder Rights .. rve Use of Net Operating Losses under Section 382
[ Thu, Sep 22nd 2011 ] - Market Wire
The Future of Ablation Therapies Conference
Wed, September 21, 2011
[ Wed, Sep 21st 2011 ] - Market Wire
Less Than Two Weeks Remain before Deadline in Cla .. tion Lawsuit against Dendreon, Says Hagens Berman
[ Wed, Sep 21st 2011 ] - Market Wire
Health Net Announces Appearance at Credit Suisse 2nd Annual Small & Mid Cap Conference
[ Wed, Sep 21st 2011 ] - Market Wire
Alnylam to Webcast Presentation at the JMP Securities Healthcare Conference
[ Wed, Sep 21st 2011 ] - Market Wire
ACADIA Pharmaceuticals to Present at the Sixth An .. ities Healthcare Conference on September 28, 2011
[ Wed, Sep 21st 2011 ] - Market Wire
ARIAD Announces Start of Enrollment in Phase 1/2 .. 3, an Investigational Dual Inhibitor of ALK and E
[ Wed, Sep 21st 2011 ] - Market Wire
Celgene Corporation to Present at JMP Securities Healthcare Conference 2011
[ Wed, Sep 21st 2011 ] - Market Wire
Independent Proxy Advisory Firms ISS and Glass Le .. hareholders Vote in Favour of Plan of Arrangement
[ Wed, Sep 21st 2011 ] - Market Wire
Smith & Nephew Introduces New Hysteroscopic Morce .. on Simulator Designed to Enhance Surgeon Training
Tue, September 20, 2011
[ Tue, Sep 20th 2011 ] - Market Wire
Jury Awards Medtronic $101 Million in Patent Suit against NuVasive
[ Tue, Sep 20th 2011 ] - Market Wire
Manny Villafaa Discusses FDA Update for Kips Bay Medical
[ Tue, Sep 20th 2011 ] - Market Wire
St. Jude Medical meldt Europese introductie van kleiner quadripolair pacingsysteem
[ Tue, Sep 20th 2011 ] - Market Wire
??????????????,?52???,2???????????????????ONGLYZAa" (????)???????(HbA1c)??
[ Tue, Sep 20th 2011 ] - Market Wire
Merck Joins Global Fight to Help Save Women's Lives During Pregnancy and Childbirth
[ Tue, Sep 20th 2011 ] - Market Wire
Pfizer Announces Expiration of Subsequent Offerin .. letion of Tender Offer for Shares of Icagen, Inc.
[ Tue, Sep 20th 2011 ] - Market Wire
Centric Health to Acquire Medical Imaging Centres Inc. and Rads 24/7 Teleradiology Consultants
[ Tue, Sep 20th 2011 ] - Market Wire
Covidien to Present at Jefferies 2011 Global Healthcare Conference
Mon, September 19, 2011
[ Mon, Sep 19th 2011 ] - Market Wire
Alere Acquires Additional Shares of Axis-Shield
[ Mon, Sep 19th 2011 ] - Market Wire
NeuroMetrix Reports Product Milestone
[ Mon, Sep 19th 2011 ] - Market Wire
Wright Medical Group, Inc. Names Robert J. Palmisano President and Chief Executive Officer
[ Mon, Sep 19th 2011 ] - Market Wire
FDA Panel to Review AtriCurea?s Synergy Ablation System on October 26
[ Mon, Sep 19th 2011 ] - Market Wire
Inhibitex Commences Dosing of Phase 2 Clinical Tr .. of INX-189 in HCV Infected Genotype 2/3 Patients
[ Mon, Sep 19th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) (saxagliptina) adicionado .. abetes tipo 2 manteve redues nos nveis de acar no
[ Mon, Sep 19th 2011 ] - Market Wire
Extensin de un estudio en fase de investigacin de .. liptina) incorporado a la insulina en adultos con
[ Mon, Sep 19th 2011 ] - Market Wire
Cord Blood America Updates Investors on Laboratory Licensing
Sun, September 18, 2011
[ Sun, Sep 18th 2011 ] - Market Wire
Sangamo BioSciences Announces Presentation of Gro .. a From ZFN Therapeutic for HIV/AIDS at ICAAC 2011
Sat, September 17, 2011
[ Sat, Sep 17th 2011 ] - Market Wire
Dans le cadre de la prolongation d'une ©tude exp .. ptine) plus insuline chez les patients adultes at
[ Sat, Sep 17th 2011 ] - Market Wire
Dans le cadre de la prolongation d'une ©tude exp .. tine) plus insuline chez les patients adultes att
[ Sat, Sep 17th 2011 ] - Market Wire
Dans le cadre de la prolongation d';&# .. 4;;; ONGLYZAa" (saxagliptine) plus insu
[ Sat, Sep 17th 2011 ] - Market Wire
Dans le cadre de la prolongation d';&# .. ntale,;;;;; ONGLYZAa" (saxagli
[ Sat, Sep 17th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic
[ Sat, Sep 17th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic
[ Sat, Sep 17th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic
[ Sat, Sep 17th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) se aggiunto a insulina in .. tipo 2 mantiene le riduzioni dei livelli di glic
Fri, September 16, 2011
[ Fri, Sep 16th 2011 ] - Market Wire
Misonix Schedules Fourth Quarter and Year-End Fis .. nference Call;; September 20, 2011 at 4:30
[ Fri, Sep 16th 2011 ] - Market Wire
NPS Pharmaceuticals Highlights Hypoparathyroidism .. al Meeting of American Society for Bone and Miner
[ Fri, Sep 16th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) toegevoegd aan insuline b .. ype 2 bood duurzame verlaging van het bloedsuiker
[ Fri, Sep 16th 2011 ] - Market Wire
ONGLYZAa" (saxagliptin) When Added to Insulin in .. aintained Reductions in Blood Sugar Levels (HbA1c
[ Fri, Sep 16th 2011 ] - Market Wire
BioLineRx to Present at Annual UBS Global Life Sciences Conference in New York on September 21st
[ Fri, Sep 16th 2011 ] - Market Wire
New data for once-daily linagliptin show durable efficacy over two years
[ Fri, Sep 16th 2011 ] - Market Wire
Centene Corporation Elects Orlando Ayala of Microsoft to Board of Directors
[ Fri, Sep 16th 2011 ] - Market Wire
Jazz Pharmaceuticals Announces Presentation at th .. e Sciences Conference in New York on September 20
Thu, September 15, 2011
[ Thu, Sep 15th 2011 ] - Market Wire
TPI Provides Updates on Jiangchuan Macrolide Facility
[ Thu, Sep 15th 2011 ] - Market Wire
What You Should Eat After a Workout
[ Thu, Sep 15th 2011 ] - Market Wire
Qualitest Pharmaceuticals Issues a Nationwide Voluntary Recall of Oral Contraceptives
[ Thu, Sep 15th 2011 ] - Market Wire
Wright Medical Group, Inc. Reaches Agreements with U.S. Attorneya?s Office and OIG
[ Thu, Sep 15th 2011 ] - Market Wire
Medtronic Announces 510(k) Clearance for the TSRH .. for the Treatment of Adolescent Idiopathic Scoli
[ Thu, Sep 15th 2011 ] - Market Wire
Five Star Quality Care, Inc. to Present at the JM .. 2011 Healthcare Conference on September 28, 2011

30 p.m. CT


//health-fitness.news-articles.net/content/2011/09/27/30-p-m-ct.html
Published in Health and Fitness on Tuesday, September 27th 2011 at 13:17 GMT, Last Modified on 2011-09-27 13:29:57 by Market Wire   Print publication without navigation


MINNEAPOLIS--([ BUSINESS WIRE ])--Vascular Solutions, Inc. (NASDAQ:VASC) today announced that it will host a live Webcast of its third quarter conference call on Tuesday, October 25th at 3:30 p.m. CT. Vascular Solutionsa™ Chief Executive Officer, Howard Root, and Chief Financial Officer, James Hennen, will discuss the companya™s third quarter results. The company will issue an earnings news release after market close on Tuesday, October 25th.

To access the Webcast, go to the investor relations portion of the companya™s website, [ http://www.vasc.com ], on the day of the conference call and click on the StreetEvents.com icon.

The Webcast is also being distributed over CCBNa™s Investor Distribution Network to both institutional and individual investors. Individual investors can listen to the call through CCBNa™s individual investor center at [ www.companyboardroom.com ].

For further information about Vascular Solutions, connect to [ http://www.vasc.com ].


Publication Contributing Sources